Shanghai Fosun Pharmaceutical (Group) Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Fosun Pharmaceutical (Group) has a total shareholder equity of CN¥56.6B and total debt of CN¥32.7B, which brings its debt-to-equity ratio to 57.7%. Its total assets and total liabilities are CN¥113.5B and CN¥56.9B respectively. Shanghai Fosun Pharmaceutical (Group)'s EBIT is CN¥1.2B making its interest coverage ratio -0.5. It has cash and short-term investments of CN¥15.6B.
Key information
57.7%
Debt to equity ratio
CN¥32.66b
Debt
Interest coverage ratio | -0.5x |
Cash | CN¥15.58b |
Equity | CN¥56.62b |
Total liabilities | CN¥56.85b |
Total assets | CN¥113.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2196's short term assets (CN¥33.8B) exceed its short term liabilities (CN¥33.8B).
Long Term Liabilities: 2196's short term assets (CN¥33.8B) exceed its long term liabilities (CN¥23.1B).
Debt to Equity History and Analysis
Debt Level: 2196's net debt to equity ratio (30.2%) is considered satisfactory.
Reducing Debt: 2196's debt to equity ratio has reduced from 69.7% to 57.7% over the past 5 years.
Debt Coverage: 2196's debt is not well covered by operating cash flow (10.5%).
Interest Coverage: 2196 earns more interest than it pays, so coverage of interest payments is not a concern.